16.11.2021 Views

epub download The Great American Drug Deal: A New Prescription for Innovative and

Copy Link to Download : https://sujimiin.blogspot.com/?book=B08FMPTBHL ***Developing life-changing drugs is risky and expensive, but that’s not what makes them unaffordable. Drug pricing is a staple of every news cycle and political debate. And while we’ve struggled for decades to agree on solutions that serve all patients without jeopardizing the invention of new medicines, many Americans suffer because they can’t afford the drugs they need. Do we really have to choose between affordability and innovation?  In The Great American Drug Deal, scientist and industry expert Peter Kolchinsky answers this question with a decisive 'no'. The pharmaceutical industry’s commitment to creating new lifesaving drugs destined to become inexpensive generics can be balanced by the healthcare system’s commitment to making those drugs affordable for all patients - a biotech social contract. Through deep research and compelling stories of breakthroughs and breakdowns, Kolchinsky presents solutions for striking a balance that are bold yet realistic and tackle today’s most pressing questions, including: Why doesn’t insurance make drugs affordable? How can we prevent price-jacking of older drugs? Why are drugs more expensive in America than elsewhere? How can we guarantee that all medicines eventually go generic so they are only temporarily expensive? What systemic failures led to the opioid crisis, and how can we prevent the next one? The Great American Drug Deal offers clear-eyed scrutiny of all players in the industry and examines vital ideas for closing loopholes, encouraging investment, dealing with bad actors, and educating consumers. It’s time we resolve to support patients and fuel discoveries that ease suffering now and for generations to come. em em

Copy Link to Download : https://sujimiin.blogspot.com/?book=B08FMPTBHL ***Developing life-changing drugs is risky and expensive, but that’s not what makes them unaffordable. Drug pricing is a staple of every news cycle and political debate. And while we’ve struggled for decades to agree on solutions that serve all patients without jeopardizing the invention of new medicines, many Americans suffer because they can’t afford the drugs they need. Do we really have to choose between affordability and innovation?  In The Great American Drug Deal, scientist and industry expert Peter Kolchinsky answers this question with a decisive 'no'. The pharmaceutical industry’s commitment to creating new lifesaving drugs destined to become inexpensive generics can be balanced by the healthcare system’s commitment to making those drugs affordable for all patients - a biotech social contract. Through deep research and compelling stories of breakthroughs and breakdowns, Kolchinsky presents solutions for striking a balance that are bold yet realistic and tackle today’s most pressing questions, including: Why doesn’t insurance make drugs affordable? How can we prevent price-jacking of older drugs? Why are drugs more expensive in America than elsewhere? How can we guarantee that all medicines eventually go generic so they are only temporarily expensive? What systemic failures led to the opioid crisis, and how can we prevent the next one? The Great American Drug Deal offers clear-eyed scrutiny of all players in the industry and examines vital ideas for closing loopholes, encouraging investment, dealing with bad actors, and educating consumers. It’s time we resolve to support patients and fuel discoveries that ease suffering now and for generations to come. em em

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.


The Great American Drug Deal: A New

Prescription for Innovative and Affordable

Medicines

Copy link in description to download this

book

Developing life-changing drugs is risky and expensive, but

that’s not what makes them unaffordable. Drug pricing is a

staple of every news cycle and political debate. And while

we’ve struggled for decades to agree on solutions that serve

all patients without jeopardizing the invention of new

medicines, many Americans suffer because they can’t afford

the drugs they need. Do we really have to choose between

affordability and innovation? In The Great American Drug

Deal, scientist and industry expert Peter Kolchinsky answers

this question with a decisive 'no'. The pharmaceutical

industry’s commitment to creating new lifesaving drugs

destined to become inexpensive generics can be balanced by

the healthcare system’s commitment to making those drugs

affordable for all patients - a biotech social contract. Through

deep research and compelling stories of breakthroughs and

breakdowns, Kolchinsky presents solutions for striking a

balance that are bold yet realistic and tackle today’s most

pressing questions, including: Why doesn’t insurance make

drugs affordable? How can we prevent price-jacking of older

drugs? Why are drugs more expensive in America

than elsewhere? How can we guarantee that all medicines

eventually go generic so they are only temporarily expensive?

What systemic failures led to the opioid crisis, and how can we

prevent the next one? The Great American Drug Deal offers

clear-eyed scrutiny of all players in the industry and examines


vital ideas for closing loopholes, encouraging investment,

dealing with bad actors, and educating consumers. It’s time we

resolve to support patients and fuel discoveries that ease

suffering now and for generations to come. em em

Developing life-changing drugs is risky and expensive, but

that’s not what makes them unaffordable. Drug pricing is a

staple of every news cycle and political debate. And while

we’ve struggled for decades to agree on solutions that serve

all patients without jeopardizing the invention of new

medicines, many Americans suffer because they can’t afford

the drugs they need. Do we really have to choose between

affordability and innovation? In The Great American Drug

Deal, scientist and industry expert Peter Kolchinsky answers

this question with a decisive 'no'. The pharmaceutical

industry’s commitment to creating new lifesaving drugs

destined to become inexpensive generics can be balanced by

the healthcare system’s commitment to making those drugs

affordable for all patients - a biotech social contract. Through

deep research and compelling stories of breakthroughs and

breakdowns, Kolchinsky presents solutions for striking a

balance that are bold yet realistic and tackle today’s most

pressing questions, including: Why doesn’t insurance make

drugs affordable? How can we prevent price-jacking of older

drugs? Why are drugs more expensive in America

than elsewhere? How can we guarantee that all medicines

eventually go generic so they are only temporarily expensive?

What systemic failures led to the opioid crisis, and how can we

prevent the next one? The Great American Drug Deal offers

clear-eyed scrutiny of all players in the industry and examines

vital ideas for closing loopholes, encouraging investment,

dealing with bad actors, and educating consumers. It’s time we

resolve to support patients and fuel discoveries that ease

suffering now and for generations to come. em em

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!